世界*實驗材料供應商 NeoClone 正式授權上海起發為其中國代理， NeoClone 在一直是行業的*,一直為廣大科研客戶提供zui為優質的產品和服務,上海起發一直秉承為中國科研客戶帶來的產品，的服務，簽約 NeoClone 就是為了給廣大科研客戶帶來更加完善的產品和服務,您的滿意將是我們zui大的收獲

 NeoClone 中國代理, NeoClone 上海代理， NeoClone 北京代理，NeoClone 廣東代理， NeoClone 江蘇代理NeoClone 湖北代理,NeoClone 天津,NeoClone 黑龍江代理,NeoClone 內蒙古代理,NeoClone 吉林代理,NeoClone 福建代理, NeoClone 江蘇代理, NeoClone 浙江代理, NeoClone 四川代理,

公司：www.neoclone。。ｃｏｍ

Through a lot of hard work, a license from the Wisconsin Alumni Research Foundation (WARF) and a desire to have an impact on human health, NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ways to discover and develop antibodies. As they refined the process to make better antibodies (what is now the NeoAb process), they established a reagent catalog as well as a service business to make high-quality antibodies for others.

By 2002 the founders realized a need to bring in business expertise to help grow the company by leveraging its ability to make excellent antibodies. This change in direction is the foundation of what NeoClone is today - a company focused on developing high quality antibodies for sale as reagents and establishing partnerships and collaborations to develop diagnostics. As a result of these efforts, we now have over 1000 customers in 30+ countries.

NeoClone has always been a research-focused company with an emphasis on emerging antibody technologies.  Reactivation is our proprietary technology for selecting, enriching, and amplifying murine or human antigen-specific antibody-producing cells. We stimulate only the class-switched (IgG), affinity matured Ig-secretors to proliferate, which increases the number of antigen -specific Ig-secreting cells relative to non-specific Ig-secreting cells. If you want to know more about this exciting technology and how it might help make better antibodies, ask to talk to our Director of Research, Rachel Kravitz, PhD, at 608-260-8190.

To poise ourselves for future success, we've continued to refine our antibody development abilities. In 2014, we added antibody phage display technology to help us develop the diverse and specific antibody repertoire to certain difficult targets that might be difficult to achieve with hybridoma technology alone. We are now developing camelid (VHH) antibody capabilities so we can service the rapidly growing therapeutics market. We have had a research team focused on this effort and we will be offering these services in 2015.

我們公司zui大優勢是強大的采購，

1：基本什么都能進口，血清，抗體，耗材，還有部分限制進口的，

2：貨品全，現經營過700多個品牌，基本所有生物試劑耗材都可以進口，特別是冷偏的產品那就更有優勢，

3：提供加急服務，一般1-2周到貨，超過時限加急費全免

4：價格公道，絕大部分價格有優勢，當然不能保證100%產品都是,因為意味著沒有服務.

5：良好的信譽，大部分客戶我們提供貨到付款服務，客戶包括清華，北大 交大 復旦，中山等100多所大學，ROCHE，阿斯利康，國藥 ，fisher等500多家公司

6：我們還是Santa,Advanced Biotechnologies Inc, NeoClone,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, GePromegaridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,NeoClone, Polysciences,prospecbi, QA-BIO,quickzyme,FULLERLABS,INC,sterlitech；sysy,TriLink BioTechnologies,Inc；worthington-biochem,zyagen等幾十家國外公司授權代理。
7：我們還是invitrogen,qiagen,NeoCloneam,sigma;Promega,roche,merck, rnd,BD, GE,pierce,BioLegend等*批發，歡迎合作。

上海起發實驗試劑有限公司
：楊建輝
400：
辦公：
*8006

企業:
:http://www.qfbio。。ｃｏｍ/
地址：上海市浦東新區晨陽路225弄東方現代商業廣場46號303室(近東亭路)